FrieslandCampina Ingredients plans to double production capacity for whey protein isolate and milk fat globule membrane
The company explains that the expansion of its Borculo plant in The Netherlands will significantly increase the total production capacity.
Borculo factory. Image courtesy of FrieslandCampina Ingredients
FrieslandCampina Ingredients is doubling its whey protein isolate and milk fat globule membrane (MFGM) production, according to a company press release. The company explains that the expansion of its Borculo plant in The Netherlands will significantly increase the total production capacity to meet the rising global demand for high quality, specialized ingredients.
“As consumers of all ages become more proactive about their health and well-being, and that of their families, they’re increasingly looking for specialized ingredients that bring the benefits they value,” said Herman Ermens, president of FrieslandCampina Ingredients, in a press release. “As a result, now is the perfect time to bolster our production of two key ingredients for the performance, active and early life nutrition markets. Thanks to our agility and technological expertise, we’re ensuring that we’re delivering the high-quality, uncompromising ingredients that will help consumers with special dietary needs or preferences to get the most out of life, always.”
“I truly believe that the future of whey lies in higher performance, specialized ingredients that make the most of dairy’s nutritional profile,” Herman added. “With over 100 years of experience in dairy proteins, from research to processing technology and application know-how, this upscaling reflects our commitment to delivering premium whey ingredients and supporting our customers in meeting evolving consumer demands.”
FrieslandCampina says that the new ingredient expansion will commence commercial production in early 2026, and that as capacity grows, the company will employ a unique combination of filtration processes to preserve whey’s bio-functionality, ensuring quality and efficacy of the final products. The company also plans on actively working on an integral reduction of CO2 emissions at the Borculo plant that is in line with FrieslandCampina’s 2050 climate plan ambitions.
Kaneka Nutrients to unveil new consumer research on menopausal women at Vitafoods Europe 2024
April 26th 2024The company will reveal the results of the research that is based on live feedback from 200 menopausal women who took 200 mg per day of Kaneka Ubiquinol over two-months, monitored the effects, and recorded their observations.
Rousselot to showcase new collagen peptide research and targeted solutions at Vitafoods Europe 2024
April 25th 2024The company will be highlighting new research that demonstrates the ability of its Peptan collagen peptide brand to support sleep quality, reduce gastrointestinal discomfort, and enhance skin health, including density, hydration, and elasticity.
